
AI-generated summary
The drug is designed to combat allergies to birch pollen and related food allergic reactions.
The Russian Ministry of Health has registered the Russian allergen vaccine “Allergarda”.
The vaccine is intended for the prevention and treatment of allergic rhinoconjunctivitis caused by sensitization to birch pollen and concomitant cross-food allergies.
MOSCOW, September 30 - RIA Novosti. The Russian Ministry of Health has registered the Russian allergen vaccine "Allergarda" for the prevention and treatment of allergic rhinoconjunctivitis, the department's press service told reporters.

The governor of the Yaroslavl region, Mikhail Evraev, said that more than 30 zemstvo doctors and paramedics will come to work in the rural areas of the region this year, including 23 doctors. To attract specialists, the “Zemsky Doctor” and “Zemsky Paramedic” programs are used with payments of up to 1.5 million rubles, new first-aid posts and outpatient clinics are being built, and modern equipment is being purchased.

Leptospirosis, transmitted through contaminated water, is spreading in the flooded city of Rayong in Thailand, where hundreds of Russians may be present. Volunteers and tourists helping to clear the rubble are at risk. As of September 30, 46 deaths were recorded.

Ohio resident Sharon Jacks, 74, has filed a lawsuit against Selby General Hospital, where her left leg was mistakenly amputated during surgery in September 2025 instead of part of her right, resulting in the subsequent loss of both legs and is seeking compensation for gross negligence and criminal negligence of the medical staff.

The Allergarda allergy vaccine has been registered in Russia for the treatment of allergic rhinoconjunctivitis. The head of the FMBA, Veronika Skvortsova, announced the favorable safety profile of the drug and the absence of serious side effects.

A University of North Dakota study of 371,000 people found that regular consumption of whole fruits reduced the risk of cardiovascular disease, unlike fruit juices, which found no such association.

The Russian Ministry of Health has registered the Allergarda vaccine for the treatment of allergic rhinoconjunctivitis. The drug is also effective in treating cross food allergies caused by birch pollen.